Codexis (LTS:0I0X) Short Percentage of Float


LTS:0I0X Codexis Inc LTS:0I0X
56 GF Score
Price $2.66
GF Value $2.54
Valuation Fairly Valued
! 6 Warning Signs
View Full Analysis

What is Codexis Short Percentage of Float?

Short Percentage of Float is the percentage of shares shorted compared to the float.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

LTS:0I0X vs KROS, CAMP, VYGR: Short Percentage of Float Comparison

For the Biotechnology subindustry, Codexis's Short Percentage of Float, along with its competitors' market caps and Short Percentage of Float data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Codexis Short Percentage of Float vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Codexis's Short Percentage of Float distribution charts can be found below:

* The bar in red indicates where Codexis's Short Percentage of Float falls into.


LTS:0I0X
56GF Score
Codexis Inc LTS:0I0X
Short Percentage of Float is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Codexis (LTS:0I0X) Overvalued in 2026?

Based on GuruFocus' analysis, Codexis stock appears to be overvalued. The current stock price of $2.66 is trading 4.7% above its estimated GF Value™ of $2.54. GuruFocus considers Codexis to be Fairly Valued.

Key valuation signals for LTS:0I0X:

  • Short Percentage of Float:
  • GF Value™: $2.54 vs. price of $2.66 (4.7% above fair value)
  • GF Score™: 56/100 with 6 warning signs

No single metric tells the full story. See the LTS:0I0X stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Codexis Business Description

Other Exchanges CDXS:USA4QK:Germany
Address 200 Penobscot Drive, Redwood City, CA, USA, 94063
Codexis Inc is a biotechnology company engaged in providing enzyme-based technology solutions to improve pharmaceutical manufacturing processes. The company operates through two key business areas: the ECO Synthesis manufacturing platform and small molecule pharma biocatalysis. The ECO Synthesis platform focuses on developing enzymatic processes for the large-scale manufacture of RNA interference therapeutics, while the biocatalysis business utilizes engineered enzymes to enhance efficiency, yield, and sustainability in small molecule drug manufacturing. Geographically, it derives maximum revenue from the Americas.
56GF Score

Get the complete analysis for LTS:0I0X

Short Percentage of Float is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.66
Price
$2.54
GF Value